Search research articles
Contact Us
Filters
Showing results (421-430 of 436) with videos related to
Page
of 44
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 30, 2019
A critique of the second consensus criteria for multiple system atrophy
Iva Stankovic, Niall Quinn, Luca Vignatelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)
Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 5, 2024
Amantadine use in the French prospective NS-Park cohort
Margherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Lancet (London, England)
|
January 17, 2015
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
Anita Kohli, Anuoluwapo Osinusi, Zayani Sims, et al.
Progress in Neurobiology
|
July 26, 2015
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F Bastide, Wassilios G Meissner, Barbara Picconi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2020
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
Alexey A Shadrin, Sören Mucha, David Ellinghaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
Max-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
The Lancet. Neurology
|
February 9, 2013
The natural history of multiple system atrophy: a prospective European cohort study
Gregor K Wenning, Felix Geser, Florian Krismer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
The New England Journal of Medicine
|
April 10, 2024
Trial of Lixisenatide in Early Parkinson's Disease
Wassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 436) with videos related to
Sort By:
Page
of 44
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 30, 2019
A critique of the second consensus criteria for multiple system atrophy
Iva Stankovic, Niall Quinn, Luca Vignatelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)
Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 5, 2024
Amantadine use in the French prospective NS-Park cohort
Margherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Lancet (London, England)
|
January 17, 2015
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
Anita Kohli, Anuoluwapo Osinusi, Zayani Sims, et al.
Progress in Neurobiology
|
July 26, 2015
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F Bastide, Wassilios G Meissner, Barbara Picconi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2020
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
Alexey A Shadrin, Sören Mucha, David Ellinghaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
Max-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
The Lancet. Neurology
|
February 9, 2013
The natural history of multiple system atrophy: a prospective European cohort study
Gregor K Wenning, Felix Geser, Florian Krismer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
The New England Journal of Medicine
|
April 10, 2024
Trial of Lixisenatide in Early Parkinson's Disease
Wassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Page
of 44